| Literature DB >> 28888662 |
David Sears1, Brian S Schwartz2.
Abstract
Candida aurisis an emerging multidrug-resistant pathogen that can be difficult to identify using traditional biochemical methods. C. auris is capable of causing invasive fungal infections, particularly among hospitalized patients with significant medical comorbidities. Echinocandins are the empiric drugs of choice for C. auris, although not all isolates are susceptible and resistance may develop on therapy. Nosocomial C. auris outbreaks have been reported in a number of countries and aggressive infection control measures are paramount to stopping transmission.Entities:
Keywords: Candida auris; Healthcare-associated; Infection control; Multidrug-resistance; Outbreak
Mesh:
Substances:
Year: 2017 PMID: 28888662 DOI: 10.1016/j.ijid.2017.08.017
Source DB: PubMed Journal: Int J Infect Dis ISSN: 1201-9712 Impact factor: 3.623